Syra Health Corp (SYRA) recent activity suggests a positive outlook with the last week’s performance of 8.33%

On Monday, Syra Health Corp (NASDAQ: SYRA) was 19.37% up from the session before settling in for the closing price of $1.20. A 52-week range for SYRA has been $0.81 – $8.37.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 98.87% over the past five years. When this article was written, the company’s average yearly earnings per share was at -26.67%. With a float of $4.90 million, this company’s outstanding shares have now reached $5.59 million.

Let’s look at the performance matrix of the company that is accounted for 162 employees.

Syra Health Corp (SYRA) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Syra Health Corp stocks. The insider ownership of Syra Health Corp is 32.49%, while institutional ownership is 1.25%. The most recent insider transaction that took place on Dec 14 ’23, was worth 385. In this transaction President and Chair of this company bought 294 shares at a rate of $1.31, taking the stock ownership to the 3,730 shares. Before that another transaction happened on Dec 14 ’23, when Company’s 10% Owner bought 175 for $1.42, making the entire transaction worth $248. This insider now owns 1,825 shares in total.

Syra Health Corp (SYRA) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -26.67% per share during the next fiscal year.

Syra Health Corp (NASDAQ: SYRA) Trading Performance Indicators

You can see what Syra Health Corp (SYRA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.71.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.19 in the next quarter

Technical Analysis of Syra Health Corp (SYRA)

Syra Health Corp (NASDAQ: SYRA) saw its 5-day average volume 0.75 million, a negative change from its year-to-date volume of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 36.53%. Additionally, its Average True Range was 0.13.

During the past 100 days, Syra Health Corp’s (SYRA) raw stochastic average was set at 36.84%, which indicates a significant decrease from 54.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.89% in the past 14 days, which was lower than the 129.07% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.3856, while its 200-day Moving Average is $1.4395. Nevertheless, the first resistance level for the watch stands at $1.7033 in the near term. At $1.9766, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2432. If the price goes on to break the first support level at $1.1634, it is likely to go to the next support level at $0.8968. The third support level lies at $0.6235 if the price breaches the second support level.

Syra Health Corp (NASDAQ: SYRA) Key Stats

There are 6,422K outstanding shares of the company, which has a market capitalization of 10.37 million. As of now, sales total 5,520 K while income totals -2,940 K. Its latest quarter income was 1,750 K while its last quarter net income were -1,450 K.